# Adjuvant Comparison and Characterization

> **NIH NIH N01** · STANFORD UNIVERSITY · 2024 · $800,000

## Abstract

The goal of the Adjuvant Comparison and Characterization (ACC) program is to support side-by-side comparison of adjuvants in combination with clinically relevant vaccine/antigen platforms, and to establish both systemic and tissue-specific immunological profiles (“immune fingerprints”) of adjuvants that work through different mechanisms in the context of Sars-CoV-2 vaccines.

## Key facts

- **NIH application ID:** 11196783
- **Project number:** 75N93022C00052-P00004-9999-4
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** BALI PULENDRAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $800,000
- **Award type:** —
- **Project period:** 2022-09-01 → 2027-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11196783

## Citation

> US National Institutes of Health, RePORTER application 11196783, Adjuvant Comparison and Characterization (75N93022C00052-P00004-9999-4). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11196783. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*